Titre:
  • Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial
Auteur:Franzoi, Maria Alice; Procter, Marion; Twelves, Chris; Pondé, Noam; Eiger, Daniel; Emond, Orianne; Clark, Emma; Parlier, Damien; Guillaume, Sébastien; Reaby, Linda; de Azambuja, Evandro; Bines, Jose
Informations sur la publication:ecancermedicalscience, 16, 1379
Statut de publication:Publié, 2022
Sujet CREF:Cancérologie
Environnement et pollution
Mots-clés:clinical trials
ethics committee/institutional review board
regulatory approval
trial activation timelines
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1754-6605
info:doi/10.3332/ecancer.2022.1379
info:scp/85140262447